3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
18
Breast Neoplasms
15
Prostatic Neoplasms
14
Colorectal Neoplasms
13
Lung Neoplasms
10
Hematopoietic and Lymphatic System Neoplasm
10
Ovarian Neoplasms
5
Hematologic Neoplasms
5
Multiple Myeloma
4
Malignant Solid Neoplasm
4
Depression
4
Uterine Cervical Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Lymphoma
3
Hematopoietic and Lymphoid System Neoplasm
3
Anxiety Disorders
3
Anatomic Stage I Breast Cancer AJCC v8
3
Advanced Malignant Solid Neoplasm
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Cancer, Papillary
2
Motor Activity
2
Melanoma
2
Malignant Female Reproductive System Neoplasm
2
Leukemia
2
Laryngeal Neoplasms
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Endometrial Neoplasms
2
Interventions
fludarabine
1
Voriconazole
1
Thalidomide
1
Semen Analysis
1
Remote Patient Monitoring
1
Physical Examination
1
Interviews as Topic
1
Health Information Exchange
1
Granulocyte Colony-Stimulating Factor
1
Genetic Testing
1
Fluconazole
1
Exercise
1
Dexamethasone
1
Cyclophosphamide
1
Complementary Therapies
1
Cell- and Tissue-Based Therapy
1
Busulfan
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
Bismuth
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hematologic Diseases
×
Interviews as Topic
×
Clear all
NCT03272789
2019-01-23
REBOND
Institut Paoli-Calmettes
Phase NA
Unknown
32 enrolled